Cargando…

Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments

This study quantified the interplay and gradient effects on GTV dose coverage for 3D CRT, dMLC IMRT, and VMAT SABR treatments for target amplitudes of 5–30 mm using 3DVH v3.1 software incorporating 4D Respiratory MotionSim (4D RMS) module. For clinically relevant motion periods (5 s), the interplay...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tyler, Madelaine K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Radiation Oncology Physics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690216/ https://www.ncbi.nlm.nih.gov/pubmed/26894347 http://dx.doi.org/10.1120/jacmp.v17i1.5781

Ejemplares similares

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
por: Goldsmith, Christy, et al.
Publicado: (2012)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Stereotactic Ablative Radiotherapy Fractionation for Hepatocellular Carcinoma in the United States
por: Sheth, Niki, et al.
Publicado: (2020)

Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor
por: Watcharawipha, Anirut, et al.
Publicado: (2023)

Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists
por: Li, Shan, et al.
Publicado: (2020)

Stability of percutaneously implanted markers for lung stereotactic radiotherapy
por: Persson, Gitte F., et al.
Publicado: (2013)

Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy
por: Miura, Hideharu, et al.
Publicado: (2014)

Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic
por: Mou, Benjamin, et al.
Publicado: (2021)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Multiple Primary Lung Cancers: Treatment Outcomes After Stereotactic Body Radiotherapy (SBRT)
por: Choi, Gyujae, et al.
Publicado: (2023)

On the reduction of aperture complexity in kidney SABR
por: Gaudreault, Mathieu, et al.
Publicado: (2021)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
por: Olson, Robert, et al.
Publicado: (2018)

Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique
por: Park, Jong In, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy as an Effective Treatment for Pancreatic Cancer
por: Hurmuz, Pervin, et al.
Publicado: (2023)

Distributive quality assurance and delivery of stereotactic ablative radiotherapy treatments amongst beam matched linear accelerators: A feasibility study
por: Rijken, James, et al.
Publicado: (2019)

SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic
por: Kidane, Biniam, et al.
Publicado: (2020)

Quantifying variability of intrafractional target motion in stereotactic body radiotherapy for lung cancers
por: Chan, Mark K.H., et al.
Publicado: (2013)

Independent review of 4DCT scans used for SABR treatment planning
por: Antony, Rachitha, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers
por: Anand, Anil Kumar, et al.
Publicado: (2020)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac
por: Vassiliev, Oleg N., et al.
Publicado: (2009)

The irregular breathing effect on target volume and coverage for lung stereotactic body radiotherapy
por: Pan, Chia‐Hsin, et al.
Publicado: (2019)

Complete PSA Response Following Stereotactic Ablative Radiotherapy for a Bony Metastasis in the Setting of Castrate-Resistant Prostate Cancer
por: Lukovic, Jelena, et al.
Publicado: (2015)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity‐modulated proton therapy
por: Ren, Xue‐Ying, et al.
Publicado: (2021)

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
por: Binkley, Michael S., et al.
Publicado: (2016)

Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
por: Ghandourh, Wsam, et al.
Publicado: (2022)

A Treatment Planning Study of Stereotactic Body Radiotherapy for Atrial Fibrillation
por: Xia, Ping, et al.
Publicado: (2016)

Development of an independent MU calculation software for radiotherapy treatments with stereotactic cones
por: Campos, Guilherme Filipe Pinto, et al.
Publicado: (2022)

A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland
por: Sharrett, Jonathan, et al.
Publicado: (2015)

Dosimetric evaluation of four‐dimensional dose distributions of CyberKnife and volumetric‐modulated arc radiotherapy in stereotactic body lung radiotherapy
por: Chan, Mark K.H., et al.
Publicado: (2013)

Stereotactic Radiotherapy for Intramedullary Spinal Arteriovenous Malformations
por: Mori, Yoshimasa, et al.
Publicado: (2018)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Optimization of the dosimetric leaf gap for use in planning VMAT treatments of spine SABR cases
por: Middlebrook, Nigel D, et al.
Publicado: (2017)

Interplay effects in highly modulated stereotactic body radiation therapy lung cases treated with volumetric modulated arc therapy
por: Fernandez, Desmond J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b902f8ccr7k4vn0h49sou1498v